GLOUCESTER, England–(BUSINESS WIRE)–$LIVN #OSA–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the two following September healthcare conferences in New York City:
- Morgan Stanley 24th Annual Global Healthcare Conference on Mon., Sept. 14, from 11:30 a.m.-12:05 p.m. EDT
- Baird 2026 Global Healthcare Conference on Tues., Sept. 15, from 11:25-11:55 a.m. EDT
Vladimir Makatsaria, Chief Executive Officer of LivaNova; Alex Shvartsburg, Chief Financial Officer; and Philip Kowalczyk, Chief Strategy and Corporate Development Officer, will participate in a fireside chat at Morgan Stanley, while Ahmet Tezel, Ph.D., Chief Innovation Officer of LivaNova, will join Makatsaria and Shvartsburg at Baird.
The discussions will be available to all interested parties who register to attend the webcasts, which are accessible via www.livanova.com/events. Listeners should log on approximately 10 minutes in advance to ensure proper webcast setup. Replays will be available on the LivaNova website within 24 hours after the live presentation.
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience with a vision to change the trajectory of lives for a new day. Through ingenious medical solutions in select neurological and cardiac conditions, LivaNova strives to ignite patient turnarounds. With its registered office in the United Kingdom, approximately 3,300 employees, and a presence in more than 100 countries, LivaNova serves patients, healthcare professionals, and healthcare systems worldwide. For more information, please visit www.livanova.com.
Safe Harbor Statement
This news release contains “forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans, underlying assumptions, and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding participation in upcoming events. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.
Contacts
LivaNova Investor Relations and Media Contacts
+1 281-895-2382
Briana Gotlin
VP, Investor Relations
[email protected]
Jim Masilak
Director, External Communications
[email protected]
